CYP24A1 and malignant colon neoplasm: This suggests that targeted inhibition of CYP24A1 could be used as a possible additional therapy for colon cancer patients with tumours overexpressing CYP24A1, whereas high dietary vitamin D3 in combination with soy could be beneficial for prevention.